| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics |
Department of Biochemistry, College of Medicine, Pusan National University, Pusan 602-739, South Korea [S. H. K., J. S. H., C. S. J., B. S. C., C. D. K.], and Department of Medical Physics and Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021 [D. K., G. C. L.]
The Ku70/80 autoantigens (Ku) are the DNA-binding components of a DNA-dependent protein kinase (PK) involved in DNA double strand breaks repairing a V(D)J recombination. Because apoptosis is associated with DNA fragmentation and, consequently, creation of double strand breaks, and a variety of DNA-damaging drugs kill tumor cells by apoptosis, we tested the impact of Ku deficiency on the sensitivity of anticancer drugs. Ku-null mutant cell lines Ku70-/- and Ku80-/- were highly sensitive to anticancer drugs, compared with their wild-type cells. Ku-deficient cells were more sensitive to bleomycin-induced DNA fragmentation and exhibited a higher level of c-jun NH2-kinase/stress-activated PK activity than wild-type cells, whereas R7080-6 cells overexpressing both human Ku70 and Ku80 were resistant to bleomycin-induced apoptosis and exhibited a lower level of c-jun NH2-kinase/stress-activated PK activity. The Ku-protein level and Ku DNA binding activity were decreased after treatment with bleomycin, adriamycin, or vincristine, and the decreases were blocked by the treatment of z-DEVD-fmk, a specific inhibitor of caspase-3, suggesting that loss of Ku DNA binding is, in part, due to a caspase-mediated decrease in Ku protein levels. By contrast, HSF1 DNA-binding activity was increased by the treatment of these anticancer drugs and, subsequently, mitochondrial heat shock protein HSP75 was specifically induced. Our data suggest that Ku can affect the susceptibility to anticancer drug-induced apoptosis.
This article has been cited by other articles:
|
|
 |
|
  J. H. Um, J. K. Kwon, C.-D. Kang, M. J. Kim, D. S. Ju, J. H. Bae, D. W. Kim, B. S. Chung, and S. H. Kim Relationship between Antiapoptotic Molecules and Metastatic Potency and the Involvement of DNA-Dependent Protein Kinase in the Chemosensitization of Metastatic Human Cancer Cells by Epidermal Growth Factor Receptor Blockade J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 1062 - 1070. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Rashmi, S. Kumar, and D. Karunagaran Ectopic expression of Bcl-XL or Ku70 protects human colon cancer cells (SW480) against curcumin-induced apoptosis while their down-regulation potentiates it Carcinogenesis, October 1, 2004; 25(10): 1867 - 1877. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Bernstein, C. M. Payne, K. Kunke, C. L. Crowley-Weber, C. N. Waltmire, K. Dvorakova, H. Holubec, C. Bernstein, R. R. Vaillancourt, D. A. Raynes, et al. A proteomic study of resistance to deoxycholate-induced apoptosis Carcinogenesis, May 1, 2004; 25(5): 681 - 692. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Y. Song, J. W. Lim, H. Kim, T. Morio, and K. H. Kim Oxidative Stress Induces Nuclear Loss of DNA Repair Proteins Ku70 and Ku80 and Apoptosis in Pancreatic Acinar AR42J Cells J. Biol. Chem., September 19, 2003; 278(38): 36676 - 36687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. S. Leskov, D. Y. Klokov, J. Li, T. J. Kinsella, and D. A. Boothman Synthesis and Functional Analyses of Nuclear Clusterin, a Cell Death Protein J. Biol. Chem., March 21, 2003; 278(13): 11590 - 11600. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-H. Kim, S.-J. Park, and S.-H. Lee A Targeted Inhibition of DNA-Dependent Protein Kinase Sensitizes Breast Cancer Cells Following Ionizing Radiation J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 753 - 759. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Townsend, H. Shen, A. L. Staros, L. Gate, and K. D. Tew Efficacy of a Glutathione S-Transferase {pi}-activated Prodrug in Platinum-resistant Ovarian Cancer Cells Mol. Cancer Ther., October 1, 2002; 1(12): 1089 - 1095. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. B. Rubinstein, A. Stortchevoi, M. Boosalis, R. Ashfaq, and T. Guillaume Overexpression of DNA-binding Protein B Gene Product in Breast Cancer as Detected by in Vitro-generated Combinatorial Human Immunoglobulin Libraries Cancer Res., September 1, 2002; 62(17): 4985 - 4991. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Sanz, L. Mir, and A. Jacquemin-Sablon Bleomycin Resistance in Mammalian Cells Expressing a Genetic Suppressor Element Derived from the SRPK1 Gene Cancer Res., August 1, 2002; 62(15): 4453 - 4458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. W. Kim, N. Noshita, T. Sugawara, and P. H. Chan Early Decrease in DNA Repair Proteins, Ku70 and Ku86, and Subsequent DNA Fragmentation After Transient Focal Cerebral Ischemia in Mice Stroke, June 1, 2001; 32(6): 1401 - 1407. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-T. Tai, G. Teoh, B. Lin, F. E. Davies, D. Chauhan, S. P. Treon, N. Raje, T. Hideshima, Y. Shima, K. Podar, et al. Ku86 Variant Expression and Function in Multiple Myeloma Cells Is Associated with Increased Sensitivity to DNA Damage J. Immunol., December 1, 2000; 165(11): 6347 - 6355. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
